GENE ONLINE|News &
Opinion
Blog

ACE2
Spike Protein
Structural Study of SARS-CoV-2 Spike Protein Aids in Better Understanding of COVID-19 Infection
2020-10-18
Spike Protein
COVID-19: Discovery of New Spike Protein Neutralizing Antibody Reveals Promising Drug Target
2020-06-28
ACE2
A Secondary Route of Viral Entry Could Explain Enhanced Pathogenicity of COVID-19
2020-06-14
Combating the Pandemic with AI and Big Data: Highlights from the “TAIWAN is Helping: AI x Pandemic Prevention Online Forum”
2020-06-03Partner
SARS
An Old SARS Antibody May Well be Our Weapon against COVID-19
2020-05-23
A Review of Neurological Symptoms in COVID-19 Patients
2020-05-18
ACE2
ACE2: A Valuable Biomarker for COVID19 Susceptibility in Heart Patients
2020-05-16
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
READ MORE
EVENT
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
2026-10-27
ESGCT 2026 (Gene & Cell Therapy)
Hamburg, Germany
SEE MORE
Scroll to Top